Gillian Cannon

Insider Reports History

Entity
Individual
Location
C/O Corcept Therapeutics Incorporated, 149 Commonwealth Drive, Menlo Park, CA
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gillian Cannon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CORCEPT THERAPEUTICS INC Director Stock option (right to buy) 30K May 17, 2024 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 15.5K Jun 5, 2024 Direct
Xenon Pharmaceuticals Inc. Director No securities are beneficially owned. 0 Aug 8, 2023 Direct

Insider Reports Filed by Gillian Cannon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
CORT CORCEPT THERAPEUTICS INC May 17, 2024 1 $0 4 May 21, 2024 Director
XENE Xenon Pharmaceuticals Inc. Aug 10, 2023 1 $0 4 Aug 10, 2023 Director
XENE Xenon Pharmaceuticals Inc. Aug 8, 2023 0 $0 3 Aug 10, 2023 Director
CORT CORCEPT THERAPEUTICS INC May 19, 2023 1 $0 4 May 23, 2023 Director
CORT CORCEPT THERAPEUTICS INC May 31, 2022 1 $0 4 Jun 2, 2022 Director
CORT CORCEPT THERAPEUTICS INC May 26, 2021 1 $0 4 May 28, 2021 Director